Latest Breaking News On - Rare enterprises - Page 5 : comparemela.com

Meet Rekha, Rakesh Jhunjhunwala s wife who has been ruling the stock market for years; know about her investment in Tata s Titan and other companies, lifestyle, net worth, and more

Meet Rekha, Rakesh Jhunjhunwala s wife who has been ruling the stock market for years; know about her investment in Tata s Titan and other companies, lifestyle, net worth, and more
financialexpress.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from financialexpress.com Daily Mail and Mail on Sunday newspapers.

India generalRekha jhunjhumwalaRakesh junhjhunwalaRakesh jhunjhunwalaWarren buffettPadma shriRekkha jhunjhunwalaTata groupIndian hotels companyTata motorsTata communicationsTitan companyBombay stock exchange indexRare enterprisesStar healthWarren buffet

Concord Biotech share price: Concord Biotech shares list at 21% premium over IPO price

Concord Biotech is a biotechnology company and a leading maker of select fermentation-based APIs across immunosuppressants and oncology in terms of market share, based on volume in 2022. The company is backed by Rakesh Jhunjhunwala s Rare Enterprises and another leading investment firm Quadria Capital Fund. Ahead of the listing, the company s shares commanded a premium of Rs 120 in the unlisted market.

Quadria capital fundRakesh jhunjhunwala rare enterprisesConcord biotechRakesh jhunjhunwalaRare enterprisesQuadria capitalMahindra capitalJefferies indiaLink intime indiaConcord biotech share priceConcord biotech stock priceConcord biotech share newsConcord biotech listingConcord biotech listing priceKotak mahindra

Rekha Jhunjhunwala-backed Concord Biotech makes market debut today

Concord Biotech Ltd, supported by RaRe Enterprises, saw its shares surge by 33.3% in early trades, reaching a valuation of over ₹10,300 crore.

India generalRekha jhunjhunwalaRakesh jhunjhunwalaBlackstone nexus selectRekha jhunjhunwala rare enterprisesNational stock exchangeForge technologyRare enterprisesConcord biotechConcord biotech limitedNational stockBig bullMankind pharmaNexus select trustHindustan timeShare sale

concord biotech share price: Concord Biotech shares list at a healthy premium What should investors do?

Concord Biotech is a biotechnology company and a leading maker of select fermentation-based APIs across immunosuppressants and oncology in terms of market share, based on volume in 2022.

Anubhuti mishraPrashant tapseQuadria capital fundEquity research analyst at swastika investmartRakesh jhunjhunwala rare enterprisesConcord biotechEquity research analystMehta equitiesRakesh jhunjhunwalaRare enterprisesQuadria capitalMahindra capitalJefferies indiaLink intime indiaEconomic timesConcord biotech share price

Investment lessons from Rakesh Jhunjhunwala s 1+1=11 partner, Utpal Sheth

Utpal Sheth teamed up with Rakesh Jhunjhunwala in the 1990s to build Rare Enterprises.He has been in Jhunjhunwala’s shadows for over 25 years, but the Big

Rakesh jhunjhunwalaUtpal shethRare enterprisesBig bullTata groupCharlie munger